Absci to Participate in the 40th Annual J.P. Morgan Healthcare Conference
January 05 2022 - 3:05PM
Absci Corporation (Nasdaq: ABSI), the drug and target discovery
company harnessing deep learning AI and synthetic biology to expand
the therapeutic potential of proteins, today announced the company
will be participating virtually in the upcoming 40th Annual J.P.
Morgan Healthcare Conference.
Absci’s management is scheduled to present on Monday, January
10th at 12:45 p.m. Pacific Time / 3:45 p.m. Eastern Time. This
presentation time has been updated from a previous announcement and
reflects the current schedule. Interested parties may access a live
and archived webcast of the presentation on the “Investors” section
of the company website via www.absci.com.
About Absci
Absci is the drug and target discovery company harnessing deep
learning and synthetic biology to expand the therapeutic potential
of proteins. We built our Integrated Drug Creation™ Platform to
identify novel drug targets, discover optimal biotherapeutic
candidates, and generate the cell lines to manufacture them in a
single efficient process. Biotech and pharma innovators partner
with us to create the next generation of protein-based drugs,
including those that may be impossible to make with other
technologies. Our goal is to enable the development of better
medicines by Translating Ideas into Drugs™. For more
information visit www.absci.com and follow us on social media:
Twitter: @Abscibio, LinkedIn: @absci.
Availability of Other Information about
Absci
Investors and others should note that we routinely communicate
with investors and the public using our website (www.absci.com) and
the “Investors” section of our website (investors.absci.com),
including without limitation, through the posting of investor
presentations, SEC filings, press releases, public conference calls
and webcasts on these websites. The information that we post on
these websites could be deemed to be material information. As a
result, investors, the media, and others interested in Absci are
encouraged to review this information on a regular basis. The
contents of our website, or any other website that may be accessed
from our website, shall not be deemed incorporated by reference in
any filing under the Securities Act of 1933, as amended.
Investor Contact
investors@absci.com
Media Contact
press@absci.com
AbSci (NASDAQ:ABSI)
Historical Stock Chart
From Apr 2024 to May 2024
AbSci (NASDAQ:ABSI)
Historical Stock Chart
From May 2023 to May 2024